Abstract:Introduction TRUC (Tbx21-/- Rag2-/- ulcerative colitis) mice spontaneously develop chronic colitis characterized by excessive TNF production by mononuclear phagocytes, and induction of pathogenic, mucosal innate lymphoid cell responses, which closely resembles aspects of human ulcerative colitis. TRUC disease is dependent on the composition of the intestinal microbiota and mechanistic insights are now needed to understand how microbially-derived metabolites drive dysregulated mucosal immune responses. Methods We performed an integrated analysis of the microbiota-associated metabolome (nuclear magnetic resonance) and host response (next-generation mRNA-sequencing). Metabolites were extracted from faecal samples TRUC and control Rag2-/- mice. Distal colon was collected for RNA sequencing. For metabonomic analysis, Principal Component Analysis was performed to display the metabolic profiles and Orthogonal Projections to Latent Structures Discriminant Analysis was utilized to determine changed metabolites. Metabolite set enrichment analysis was done with MetaboAnalyst. Differential gene expression was calculated by DESeq2. Gene set enrichment analysis was carried out with clusterProfiler. Pathway mapping with both gene and metabolites was achieved with Pathview. Results The faecal metabolome of TRUC mice was distinct from Rag2-/- mice, including significantly increased dimethylamine, lysine, alanine, hypoxanthine, glycerol, pyruvate, 4-aminobutyrate, galactose, aspartate and butyrate, while tyramine was decreased. Metabolite set enrichment analysis showed that amino acids metabolism (lysine, alanine, aspartate, glutamate, arginine, proline) and energy-related metabolism (glycolysis, gluconeogenesis, citric cycle) were the most enriched pathways. Integration of gene and metabolic pathway analyses demonstrated increased expression of transcripts involved pyruvate biosynthesis, and modulation of glucose and amino acid metabolism (figure 1A). Gene set enrichment analysis identified cytokine/chemokine signalling, pathogen phagocytosis and complement activation among the 5 most significantly enriched biological pathways (figure 1B). Conclusions In TRUC colitis there is marked dysregulation of the microbiota-associated metabolome and disruption of key host metabolic pathways, including energy and amino acids metabolism, which is associated with perturbed mucosal immune function. Integrated analysis of the microbiome-metabolome-immune response axis is warranted to determine whether therapeutic targeting of key metabolic pathways can be harnessed as novel therapies.

Dysregulation of CD177+ neutrophils on intraepithelial lymphocytes exacerbates gut inflammation via decreasing microbiota-derived DMF

Dysregulation of CD177+ neutrophils on intraepithelial lymphocytes exacerbates gut inflammation via decreasing microbiota-derived DMF

Immune Regulatory Mechanisms of CD177+ Neutrophils in the Pathogenesis of Inflammatory Bowel Disease

CD177 neutrophils as functionally activated neutrophils negatively regulate IBD.

CD177+ Neutrophils and Its Correlation with Mucosal Impairment in Patients with Inflammatory Bowel Disease

Monocyte Chemotactic Protein 1-Induced Protein 1 is Highly Expressed in Inflammatory Bowel Disease and Negatively Regulates Neutrophil Activities

Blockage of Tumor Necrosis Factor Prevents Intestinal Mucosal Inflammation Through Down-Regulation of Interleukin-23 Secretion

Neutrophils Promote Amphiregulin Production in Intestinal Epithelial Cells through TGF-β and Contribute to Intestinal Homeostasis

Epithelial chemerin-CMKLR1 signaling restricts microbiota-driven colonic neutrophilia and tumorigenesis by up-regulating lactoperoxidase

Clostridioides Difficile Aggravates Dextran Sulfate Solution (Dss)-Induced Colitis by Shaping the Gut Microbiota and Promoting Neutrophil Recruitment

Fusobacterium Nucleatum Aggravates Intestinal Barrier Impairment and Colitis Through IL-8 Induced Neutrophil Chemotaxis by Activating Epithelial Cells

C-X-C Motif Chemokine Ligand 1 Promotes Colitis by Modulating the Gut Microbiota

Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-κB pathway in Crohn's disease

Downregulation of microRNA-107 in intestinal CD11c(+) myeloid cells in response to microbiota and proinflammatory cytokines increases IL-23p19 expression.

Dual role of CD177 + neutrophils in inflammatory bowel disease: a review

Synergistic Action of Diclofenac with Endotoxin-Mediated Inflammation Exacerbates Intestinal Injury in Vitro

The epithelial C15ORF48/miR-147-NDUFA4 axis is an essential regulator of gut inflammation, energy metabolism, and the microbiome

Neutrophils mediate protection against colitis and carcinogenesis by controlling bacterial invasion and IL-22 production by γδ T cells

O31 Dysregulated Gut Microbiota-Host Metabolism Underpins Immune Activation in a Microbiota-Dependent Model of Ulcerative Colitis

IDDF2022-ABS-0204 Decreased TMIGD1 Promotes Colitis and Intestinal Barrier Dysfunction: a Novel Therapeutic Target for Crohn’s Disease

Short chain fatty acids regulation of neutrophil production of IL-10